VBI Vaccines Inc (21)

Browse by Contract Category

Contracts

Contribution Agreement, dated September 16, 2020, by and among VBI Vaccines, Inc., Variation Biotechnologies, Inc. and Her Majesty The Queen in Right of Canada as Represented by... (Filed With SEC on November 2, 2020)
Lease agreement dated September 4, 2020, between 310 Hunt Club Limited and Variation Biotechnologies Inc (Filed With SEC on November 2, 2020)
Collaborative Research Agreement between National Research Council of Canada and Variation Biotechnologies Inc effective March 30, 2020 (Filed With SEC on May 6, 2020)
Amendment to Consulting Agreement with F. Diaz-Mitoma Professional Corporation, effective January 1, 2020 (Filed With SEC on March 5, 2020)
Collaboration and License Agreement, dated December 4, 2018, between VBI Vaccines, Inc. and Brii Biosciences Limited (Filed With SEC on February 25, 2019)
Form of Warrant (Filed With SEC on May 27, 2020)
Loan and Guaranty Agreement, dated as of May 22, 2020, by and among VBI Vaccines Inc., as borrower, Variation Biotechnologies Inc., as borrower representative, each of the... (Filed With SEC on May 27, 2020)
Fifth Amendment to lease agreement among American Twine Limited Partnership and Variation Biotechnologies (US) Inc (Filed With SEC on May 6, 2020)
Sixth Amendment to lease agreement among American Twine Limited Partnership and Variation Biotechnologies (US) Inc (Filed With SEC on May 6, 2020)
Seventh Amendment to lease agreement among American Twine Owner LLC and Variation Biotechnologies (US), Inc (Filed With SEC on May 6, 2020)
Form of Warrant Agreement (Filed With SEC on April 27, 2020)
Underwriting Agreement, dated April 22, 2020, by and among the Company and Raymond James & Associates, Inc. and Oppenheimer & Co. Inc., as representatives of the several... (Filed With SEC on April 24, 2020)
Waiver Agreement, dated February 25, 2020, by and among Variation Biotechnologies (US), Inc., the Guarantors party thereto, and Perceptive Credit Holdings, LP (Filed With SEC on March 5, 2020)
Description of Securities (Filed With SEC on March 5, 2020)
Lease extension and amending agreement, dated September 5, 2019, pursuant to the Sub-Sublease, dated September 1, 2014, between Iogen Corporate and the Variation Biotechnologies... (Filed With SEC on November 6, 2019)
Underwriting Agreement, dated September 19, 2019, by and among the Company and Raymond James & Associates, Inc. and Oppenheimer & Co. Inc., as representatives of the several... (Filed With SEC on September 20, 2019)
Stock Purchase Agreement, dated December 4, 2018, between VBI Vaccines, Inc. and Brii Biosciences Limited (Filed With SEC on February 25, 2019)
Waiver Agreement, dated February 14, 2019, by and among Variation Biotechnologies (US), Inc., the Guarantors party thereto, and Perceptive Credit Holdings, LP (Filed With SEC on February 25, 2019)
Amendment to Consulting Agreement with F. Diaz-Mitoma Professional Corporation, effective January 1, 2019 (Filed With SEC on February 25, 2019)
Amendment to Sublease Lease, dated January 15, 2019, by and between Green Power YE and SciVac Ltd (Filed With SEC on February 25, 2019)
Amendment No. 3 to Amended and Restated Credit Agreement and Guaranty and Amendment to Warrant, dated January 31, 2019, by and among Variation Biotechnologies (US), Inc., the... (Filed With SEC on February 5, 2019)